| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/31/2006 | EP1660685A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 05/31/2006 | EP1660678A2 Mutant adeno-associated virus virions and methods of use thereof |
| 05/31/2006 | EP1660674A2 Expression profiling using microarrays |
| 05/31/2006 | EP1660658A2 The use of sirna silencing in the prevention of metastasis |
| 05/31/2006 | EP1660656A2 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia |
| 05/31/2006 | EP1660654A1 Expression vector |
| 05/31/2006 | EP1660650A2 Improved sso7-polymerase conjugate proteins |
| 05/31/2006 | EP1660646A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660631A2 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 05/31/2006 | EP1660628A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 05/31/2006 | EP1660537A2 Endotheliase-2 ligands |
| 05/31/2006 | EP1660534A2 Humanization of antibodies |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP1660515A2 Nucleic acid analysis method conducted in small reaction volumes |
| 05/31/2006 | EP1660514A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660512A2 Oligonucleotide synthesis with alternative solvents |
| 05/31/2006 | EP1660186A2 Humanization of antibodies |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1660099A1 Intravascular delivery of non-viral nucleic acid |
| 05/31/2006 | EP1613768A4 Reca-assisted allele specific oligonucleotide extension method |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1261617B1 Methods for assay and detection on a microarray |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1108006A4 Self-contained device integrating nucleic acid extraction, amplification and detection |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP1056887B1 Methods for determination of length polymorphisms in dna |
| 05/31/2006 | EP1045027B1 Novel gene having reverse transcriptase motif |
| 05/31/2006 | EP0888456B1 Prostate specific antigen oligo-epitope peptide |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN1780922A Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 05/31/2006 | CN1780920A Gene expression suppression agents |
| 05/31/2006 | CN1780848A Compositions and methods to initiate or enhance antibody and major-histocompatibility class i or class ii-restricted t cell responses by using immunomodulatory, non-coding RNA motifs |
| 05/31/2006 | CN1778918A SiRNA for inhibiting Stat3 gene expression and preparation thereof |
| 05/31/2006 | CN1257985C Method for detection of susceptibility mutations for ototoxic deafness |
| 05/30/2006 | US7053269 Construction of a recombinant DNA construct encoding the phospholipid, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the phospholipid |
| 05/30/2006 | US7053265 Nucleotide sequences for use as tools in the expression of heterologous gene in plants |
| 05/30/2006 | US7053208 Dioxetane probes for use as signaling tool in biological analysis |
| 05/30/2006 | US7053207 L-ribo-LNA analogues |
| 05/30/2006 | US7053206 Methods and compositions for multiplex amplification of nucleic acids |
| 05/30/2006 | US7053205 for initiation of transcription; for production of transgenic plants |
| 05/30/2006 | US7053204 Polypeptides, nucleic acids; gene codes; antibiotic, immunosuppressants |
| 05/30/2006 | US7053202 Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor |
| 05/30/2006 | US7053201 GP-83 protein (human epididymis-associated disintegrin and metalloprotease 7 protein) or h-ADAM7 |
| 05/30/2006 | US7053200 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation |
| 05/30/2006 | US7053199 triplexes/regulatory sequences for controlling gene expression; antisense agents; nuclease resistance |
| 05/30/2006 | US7053198 Functionated photoacid generator and functionated polymer system for biological microarray synthesis |
| 05/30/2006 | US7053197 Ketogulonigenium endogenous plasmids |
| 05/30/2006 | US7053196 Ketogulonigenium endogenous plasmids |
| 05/30/2006 | US7053195 Locked nucleic acid containing heteropolymers and related methods |
| 05/30/2006 | US7053194 Compositions and methods for p53-mediated repression of gene expression |
| 05/30/2006 | US7053193 Up-regulated breast cancer transcription factor amino acid sequence |
| 05/30/2006 | US7053062 Compositions and methods for inducing gene expression |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052903 Compositions and methods for activating genes of interest |
| 05/30/2006 | US7052895 nucleotide sequences that code amino acid sequences having hydrolase enzyme activity, used for medical diagnosis, for prophylaxis of diseases and drug screening; bioassay |
| 05/30/2006 | US7052892 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 05/30/2006 | US7052890 Transglutaminase gene products |
| 05/30/2006 | US7052889 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
| 05/30/2006 | US7052888 ACTR-1 a novel human acyltransferase and uses thereof |
| 05/30/2006 | US7052879 Recombinant Candida rugosa lipases |
| 05/30/2006 | US7052878 Serotype and dengue group specific flurogenic probe based PCR (TaqMan) assays against the respective C and NS5 genomic and 3′ non-coding regions of dengue virus |
| 05/30/2006 | US7052876 generating DNA libraries having variable lengths and sequences comprising ligation of DNA molecules having receptivity to one another and are equivalent to the cleavage products of different but compatible restriction enzymes and cutting to desired orientation |
| 05/30/2006 | US7052875 stabilization of aqueous solutions of DNA by mixing with citric acid or tartaric acid and atelocollagen, and freeze drying; gene therapy |
| 05/30/2006 | US7052869 Obtaining a consensus protein from a group of amino acid sequences of a defined protein family |
| 05/30/2006 | US7052865 culturing specialized cells around blood vessels in the kidneys in the presence of transforming growth factors and glucose, to induce gene expression, then analyzing by suppression subtractive hybridization; diagnostic labels; drug design |
| 05/30/2006 | US7052863 Chromogenic substrate for use in monitoring and detecting preferential enzymatic activities |
| 05/30/2006 | US7052862 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052848 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof |
| 05/30/2006 | US7052847 solid phase synthesis using a mixture of nucleotides and nucleotide analogs, and a supported target DNA and DNA polymerase; template directed extension of a primer; spectrum analysis |
| 05/30/2006 | US7052846 kit for genotyping DNA using an amplification primer having a tag and linker attached to the 3' end of the DNA strand; linker allows the tag to be cleaved and detected by mass spectrometry |
| 05/30/2006 | US7052845 Oligonucleotide for use as diagnostic tool in detection of hereditary blood disorder |
| 05/30/2006 | US7052843 Transcription-based assay for identification of post-translational modification and its application in proteomics |
| 05/30/2006 | US7052842 Method for highly sensitive hybridization of nucleic acids, and method for gene analysis using the same |
| 05/30/2006 | US7052841 Systems, tools and methods of assaying biological materials using spatially-addressable arrays |
| 05/30/2006 | US7052840 Reversible association of nucleic acid with a carboxylated substrate |
| 05/30/2006 | US7052839 Detection of preferential nucleotide sequences in sample; obtain sample, incubate with amplification reaction mixture and label, expose to hydrolase, detect label |
| 05/30/2006 | US7052838 Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction |
| 05/30/2006 | US7052837 Nucleotide sequences for use in the detection of histoplasma infections |
| 05/30/2006 | US7052836 Probes specific for five different species of Aspergillus, three of Fusarium, four of Mucor, two of Penecillium, five of Rhizopus, and one of Rhizomucor, Absidia, Cunninghamella, Pseudallescheria and Sporothrix |
| 05/30/2006 | US7052834 Tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein |
| 05/30/2006 | US7052830 diagnosing infection by way of binding an antibody or antigen reading frame then translating open; vaccines |
| 05/30/2006 | US7052704 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 05/30/2006 | US7052698 Surface proteins of Leptospira |
| 05/30/2006 | US7052692 increasing transcription via inhibition of D-sequence-binding protein (D-BP), which is phosphorylated at tyrosine residues for blocking Adeno-mediated transgene expression in infected cells; inhibiting protein kinase activity; cancer treatment |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2006 | CA2242767C Glycosidase enzymes |
| 05/30/2006 | CA2165971C Methylphosphonic acid ester, process for preparing the same and its use |
| 05/26/2006 | WO2006055524A2 Biomarkers for diagnosing schizophrenia and bipolar disorder |
| 05/26/2006 | WO2006055322A2 High arachidonic acid producing strains of yarrowia lipolytica |
| 05/26/2006 | WO2006054979A1 Abnormalities of phosphatase 2a (pp2a) for diagnosis and treatment of alzheimer’s disease |
| 05/26/2006 | WO2006054297A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 05/26/2006 | WO2006053430A1 Sirna silencing of apolipoprotein b |
| 05/26/2006 | WO2006019388A3 Cleavable solid phases for isolating nucleic acids |
| 05/26/2006 | WO2005121370A3 Oligomeric compounds that facilitate risc loading |